Yeah I'm not so sure on a Q2 deal being done, but I would think that great results from the current trial at the end of June will help confirm to any partners that they need to be a part of this before it runs away from them. If we look over why the CR was done then we can quite clearly see that any leverage used by potentials will soon be defunct.
Hey, I agree that past communications to shareholders about the deal left a lot to be desired, but did anyone think that the CEO was going to push the "sell now" button??
So here we are now, to believe or not to. I believe the market needs it, I believe that the experts who have spent their time to validate it and I believe that no matter what management do we will see VitroGro as a big part of wound healing in the future, I also believe that management know where to go from here.
My thoughts
TIS Price at posting:
49.5¢ Sentiment: LT Buy Disclosure: Held
